Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: In search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis

Brett P. Bielory, Victor L Perez Quinones, Leonard Bielory

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Purpose of review: Corticosteroids are an effective short-term treatment option for seasonal allergic conjunctivitis (SAC). Their use has been limited due to their side effects and has led to the development of modified 'soft', 'smart' ophthalmic corticosteroid formulations that retain their anti-inflammatory mechanism of action with an improved safety profileRecent findings: Similar to the development of the prodrug concept for the nose and lung that led to the development of ciclesonide, a chloromethyl-ester group substitution at the carbon-20 (C-20) position of the traditional corticosteroid has led to the development of a family of potential ophthalmic corticosteroids including loteprednol etabonate that has demonstrated similar efficacy to the C-20 ketone corticosteroids in the treatment of the signs and symptoms of ocular allergies, but less likely to induce elevations in intraocular pressure (IOP) or the formation of cataracts. The C-20 ester corticosteroid, loteprednol etabonate has been designed to be rapidly converted to an inactive, nontoxic metabolite, thus minimizing adverse effects, and loteprednol etabonate (0.2%) is currently the only ophthalmic corticosteroid specifically developed for and approved by the Food and Drug Administration for treatment of SAC. Summary: The development of modified or soft, smart corticosteroids such as loteprednol etabonate provides an avenue for expanding the treatment of the inflammation associated with signs and symptoms in patients with chronic forms or severe acute exacerbations of allergic conjunctivitis. Modified corticosteroids are an effective and well tolerated option for the short-term treatment of the inflammation and signs and symptoms associated with SAC.

Original languageEnglish
Pages (from-to)469-477
Number of pages9
JournalCurrent Opinion in Allergy and Clinical Immunology
Volume10
Issue number5
DOIs
StatePublished - Oct 1 2010

Fingerprint

Allergic Conjunctivitis
Adrenal Cortex Hormones
Signs and Symptoms
Therapeutics
Inflammation
Prodrugs
United States Food and Drug Administration
Ketones
Intraocular Pressure
Nose
Cataract
Hypersensitivity
Esters
Anti-Inflammatory Agents
Carbon
Safety
Lung

Keywords

  • C-20 esters
  • loteprednol etabonate
  • seasonal allergic conjunctivitis
  • smart ophthalmic corticosteroids
  • soft corticosteroids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids : In search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis. / Bielory, Brett P.; Perez Quinones, Victor L; Bielory, Leonard.

In: Current Opinion in Allergy and Clinical Immunology, Vol. 10, No. 5, 01.10.2010, p. 469-477.

Research output: Contribution to journalArticle

@article{2fc97c0e98e4485aa8c478aeebf1febf,
title = "Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: In search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis",
abstract = "Lippincott Williams & Wilkins.",
keywords = "C-20 esters, loteprednol etabonate, seasonal allergic conjunctivitis, smart ophthalmic corticosteroids, soft corticosteroids",
author = "Bielory, {Brett P.} and {Perez Quinones}, {Victor L} and Leonard Bielory",
year = "2010",
month = "10",
day = "1",
doi = "10.1097/ACI.0b013e32833dfa28",
language = "English",
volume = "10",
pages = "469--477",
journal = "Current Opinion in Allergy and Clinical Immunology",
issn = "1528-4050",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids

T2 - In search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis

AU - Bielory, Brett P.

AU - Perez Quinones, Victor L

AU - Bielory, Leonard

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Lippincott Williams & Wilkins.

AB - Lippincott Williams & Wilkins.

KW - C-20 esters

KW - loteprednol etabonate

KW - seasonal allergic conjunctivitis

KW - smart ophthalmic corticosteroids

KW - soft corticosteroids

UR - http://www.scopus.com/inward/record.url?scp=77956260363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956260363&partnerID=8YFLogxK

U2 - 10.1097/ACI.0b013e32833dfa28

DO - 10.1097/ACI.0b013e32833dfa28

M3 - Article

C2 - 20720489

AN - SCOPUS:77956260363

VL - 10

SP - 469

EP - 477

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

SN - 1528-4050

IS - 5

ER -